Stocks
AxoGen Financial Statements (AXGN) |
||||||||||
| AxoGensmart-lab.ru | % | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 09.05.2023 | 08.08.2023 | 07.11.2023 | 05.03.2024 | 02.05.2024 | 02.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 36.7 | 38.2 | 41.3 | 42.9 | 41.4 | 163.7 | |||
| Operating Income, bln rub | -7.34 | -6.90 | -4.03 | -3.19 | -4.56 | -18.7 | ||||
| EBITDA, bln rub | ? | -6.18 | -6.13 | -2.62 | -1.34 | -2.66 | -12.8 | |||
| Net profit, bln rub | ? | -6.71 | -6.66 | -4.09 | -3.89 | -6.64 | -21.3 | |||
| OCF, bln rub | ? | -7.42 | 0.292 | 1.63 | -0.211 | -12.3 | -10.6 | |||
| CAPEX, bln rub | ? | 4.56 | 4.68 | 3.91 | 1.78 | 1.34 | 11.7 | |||
| FCF, bln rub | ? | -12.0 | -4.39 | -2.28 | -1.99 | -13.6 | -22.3 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 37.3 | 37.8 | 37.3 | 37.0 | 37.2 | 149.2 | ||||
| Cost of production, bln rub | 6.71 | 7.23 | 8.04 | 9.16 | 8.76 | 33.2 | ||||
| R&D, bln rub | 6.68 | 7.36 | 6.99 | 7.30 | 7.41 | 29.1 | ||||
| Interest expenses, bln rub | 0.016 | 0.148 | 0.827 | 1.89 | 2.33 | 5.19 | ||||
| Assets, bln rub | 189.5 | 191.6 | 194.6 | 196.8 | 186.5 | 186.5 | ||||
| Net Assets, bln rub | ? | 97.5 | 97.2 | 97.8 | 95.7 | 93.2 | 93.2 | |||
| Debt, bln rub | 67.1 | 67.3 | 67.4 | 69.3 | 69.2 | 69.2 | ||||
| Cash, bln rub | 37.9 | 34.5 | 32.6 | 37.0 | 23.6 | 23.6 | ||||
| Net debt, bln rub | 29.2 | 32.8 | 34.8 | 32.3 | 45.5 | 45.5 | ||||
| Ordinary share price, rub | 9.45 | 9.13 | 5.00 | 6.83 | 8.07 | 3.79 | ||||
| Number of ordinary shares, mln | 42.6 | 42.9 | 43.0 | 43.0 | 43.2 | 43.2 | ||||
| Market cap, bln rub | 402 | 391 | 215 | 294 | 349 | 164 | ||||
| EV, bln rub | ? | 431 | 424 | 250 | 326 | 394 | 209 | |||
| Book value, bln rub | 94 | 93 | 94 | 91 | 88 | 88 | ||||
| EPS, rub | ? | -0.16 | -0.16 | -0.10 | -0.09 | -0.15 | -0.49 | |||
| FCF/share, rub | -0.28 | -0.10 | -0.05 | -0.05 | -0.31 | -0.51 | ||||
| BV/share, rub | 2.20 | 2.17 | 2.17 | 2.12 | 2.04 | 2.04 | ||||
| EBITDA margin, % | ? | -16.9% | -16.1% | -6.36% | -3.12% | -6.44% | -7.79% | |||
| Net margin, % | ? | -18.3% | -17.5% | -9.91% | -9.07% | -16.0% | -13.0% | |||
| FCF yield, % | ? | -8.11% | -6.90% | -11.2% | -7.02% | -6.38% | -13.6% | |||
| ROE, % | ? | -23.4% | -22.8% | -23.1% | -22.3% | -22.8% | -22.8% | |||
| ROA, % | ? | -12.0% | -11.6% | -11.6% | -10.8% | -11.4% | -11.4% | |||
| P/E | ? | -17.7 | -17.7 | -9.52 | -13.8 | -16.4 | -7.70 | |||
| P/FCF | -12.3 | -14.5 | -8.94 | -14.2 | -15.7 | -7.36 | ||||
| P/S | ? | 2.79 | 2.65 | 1.41 | 1.85 | 2.13 | 1.00 | |||
| P/BV | ? | 4.30 | 4.20 | 2.30 | 3.23 | 3.95 | 1.85 | |||
| EV/EBITDA | ? | -20.4 | -20.7 | -12.8 | -20.1 | -30.9 | -16.4 | |||
| Debt/EBITDA | -1.38 | -1.60 | -1.79 | -1.98 | -3.57 | -3.57 | ||||
| R&D/CAPEX, % | 146.6% | 157.4% | 178.9% | 410.9% | 552.5% | 248.4% | ||||
| CAPEX/Revenue, % | 12.4% | 12.3% | 9.46% | 4.14% | 3.24% | 7.15% | ||||
| AxoGen shareholders | ||||||||||
